Fedratinib hydrochloride hydrate

Fedratinib hydrochloride hydrate (TG-101348 hydrochloride hydrate, SAR 302503 hydrochloride hydrate) is a small-molecule, ATP-competitive inhibitor of JAK2 with IC50s of 3 nM for both JAK2 and JAK2V617F kinase. It induces cancer cell apoptosis and has potential for efficacious treatment of JAK2V617F-associated myeloproliferative disease.

Price Not Available 100mg Fedratinib hydrochloride hydrate Supplier Page

Trivial name	TG-101348 hydrochloride hydrate, SAR 302503 hydrochloride hydrate
Catalog Number	E5818
Molecular Formula	C9H11FN2O5
CAS#	1374744-69-0
Inchi	InChI=1S/C9H11FN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1
Inchi Key	ODKNJVUHOIMIIZ-RRKCRQDMSA-N
SMILES	C1C(C(OC1N2C=C(C(=O)NC2=O)F)CO)O
Size	100mg
Supplier Page	http://www.selleckchem.com/products/fedratinib-hydrochloride-hydrate.html
Additional Information	https://file.selleck.cn/downloads/struct/E5818-Fedratinib-hydrochloride-hydrate-chemical-structure.png